Libby P, Ridker P M, Hansson G K. Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011, 473(7347):？ 317-325. [2]Hillaert M A, Lentjes E G, Beygui F, et al. Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data[J]. Am Heart J, 2011, 162(4):？ 585-596. [3]Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9[J]. Circ Res, 2000, 87(5):？ E1-E9. [4]Iwai M, Horiuchi M. Role of the ACE2/angiotensin1-7/Mas axis in the cardiovascular system[J]. Hypertens Res, 2010, 33(11):？ 1108-1109. [5]Peters S A, den-Ruijter H M, Bots M L, et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis:？ a systematic review[J]. Heart, 2012, 98(3):？ 177-184. [6]Arshinov A B, Maslova I G. Role of the infection and inflammation in atherosclerosis development (literature review)][J]. Angiol Sosud Khir, 2010, 17(1):？ 35-41. [7]Holthe M R, Andersson Y, Lyberg T. Lack of proinflammatory effects of free fatty acids on human umbilical cord vein endothelial cells and leukocytes[J]. Acta Obstet Gynecol Scand, 2005, 84(7):？ 672-678. [8]Ferreira A J, Bader M, Santos R A. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system:？ a patent review[J]. Expert Opin Ther Pat, 2012, 22(5):？ 567-574. [9]Thomas M C, Pickering R J, Tsorotes D, et al. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse[J]. Circ Res, 2010, 107(7):？ 888- 897. [10]Thatcher S E, Zhang X, Howatt D A, et al. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice[J]. Arterioscler Thromb Vasc Biol, 2011, 31(4):？ 758-765. [11]Rabelo L A, Alenina N, Bader M. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease[J]. Hypertens Res, 2011, 34(2):？ 154-160. [12]Yang J M, Dong M, Meng X, et al. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells[J]. Arterioscler Thromb Vasc Biol, 2013, 33(8):？ 1978-1985. [13]Breen L T, McHugh P E, Murphy B P. HUVEC ICAM-1 and VCAM-1 synthesis in response to potentially athero-prone and athero-protective mechanical and nicotine chemical stimuli[J]. Ann Biomed Eng, 2010, 38(5):？ 1880-1892. [14]Liu H Q, Wei X B, Sun R, et al. Angiotensin Ⅱ stimulates intercellular adhesion molecule-1 ？via？ an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells[J]. Life Sci, 2006, 78(12):？ 1293-1298. [15]He H L, Liu L, Chen Q H, et al. MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS[J]. J Cell Physiol, 2015, 230(3): 691-701.
[2]
雷泽源,黄跃生,肖蓉,等.大鼠严重烧伤早期RAS的变化对心功能及心肌损害的影响[J].第三军医大学学报,2008,30(19):1779. LEI Ze-yuan,HUANG Yue-sheng,XIAO Rong,et al.Roles of renin-angiotension system in cardiac mechanics and myocardial damage at early stage following severe scald in rats[J].J Third Mil Med Univ,2008,30(13):1779.
